Board of Trustees 2024-2025

A native of Louisiana, J. Renea Austin-Duffin is an accomplished and proven leader in the private sector and government. She earned her Bachelor of Science degree in Business/Public Administration from Louisiana State University and a Master of Public Administration degree from Southern University.

Upon completing her Master’s degree, Renea served her state for 13 years in both the legislative and executive branches. From 1996 through 2001, Renea served in Governor Mike Foster’s administration as first, the undersecretary of the Department of Social Services, then Deputy Commissioner of Administration for Policy, and ultimately Secretary of the Department of Social Services during his second term. Renea joined the state’s largest private health insurer, Blue Cross Blue Shield of Louisiana, in November 2001 as Senior Vice President for Member and Community Relations. She also served as the Corporate Diversity Officer and President of the Blue Cross Blue Shield of Louisiana Foundation.

In summer 2006 Renea put her professional career on pause and became full-time caregiver to her sister who was living with cancer. This life changing experience inspired her to seek “success with significance”. Since February 2007 she has served as the Vice-President of Cancer Support and Outreach at Mary Bird Perkins Cancer Center. She is responsible for the oversight and strategic development for mission-based programs and services within a 30-parish service area to lessen the burden of cancer in the community. These programs include education, research and early detection, including the management of three mobile medical clinics. She also responsible for the Cancer Centers grants management program which has a portfolio of grants in excess of $5 million. Renea also serves as the governmental affairs liaison for the Cancer Center at local, state and federal level.

While her professional career and community service are important, she views her most challenging and rewarding role as those of wife to her husband, Morise L. Duffin, Jr., and mother to her son, Morise L. Duffin, III (Trey) who is a junior at Xavier University of Louisiana.

Before becoming the executive director of Life with Cancer and Patient Experience for the Inova Schar Cancer Institute, Jennifer Bires served as the executive director at Smith Center for Healing and the Arts in Washington, D.C., after almost a decade of experience as an oncology social worker in the D.C. area. Bires has a passion for improving access to psychosocial services for those impacted by cancer. She specializes in working with young adults who have been diagnosed with cancer, end-of-life issues for patients and families, and sexual health. Jennifer is the 2017 recipient of the Oncology Social Worker of the Year Award from the Association of Oncology Social Workers.

Dr. Jiajoyce R. Conway is a practicing clinician with over 25 years of invaluable clinical experience in medical and hematology oncology, with a special focus on bone marrow transplant and blood cancers. She initially obtained her Bachelor of Science in Nursing at Coppin University and went on to earn her Master of Science in Nursing with a specialization in Family Nursing Practice, also from Coppin University. Dr. Conway continued to further her nursing education at Chatham University in Pittsburgh, where she obtained her Doctor of Nursing Practice. In addition to her nursing degrees, she also earned her Master of Theology degree from Liberty University.

Passionate about enhancing patient outcomes, Dr. Conway is dedicated to palliative care and providing holistic care with the goal of empowering patients to engage in their health outcomes in any capacity they are able. Her commitment extends to educating healthcare professionals on the impact of social determinants of health, early palliative care interventions, and preventive health measures in improving survival rates and overall quality of life. Driven by the belief that patient education is paramount, she strives to enlighten individuals about the factors influencing their decision-making, well-being, and perceptions of their diseases.

Beyond her clinical practice, Dr. Conway is a published author with articles addressing symptom management, breast cancer in pregnancy, and palliative care in high-risk patients. She developed a high-risk assessment tool, utilizing age and social determinants of health, to aid decision-making in chemotherapy treatment for high-risk oncology patients. She has also spoken on national and local oncology platforms and engages in community outreach and education initiatives.

Matt Manning is a radiation oncologist in Greensboro, North Carolina, with broad experience in community oncology, clinical research and advocacy. Manning earned his degree in chemistry at The College of William and Mary and completed his medical school and residency at the VCU School of Medicine.

Manning joined Cone Health in 2001, implementing advanced technology such as IMRT, SRS and SBRT. He served as the Medical Director of Stereotactic Radiosurgery and Medical Director of Radiation Oncology. He also served as the Cone Health Chief of Oncology, leading radiation and medical oncology for six cancer campuses from 2019 through 2021.

Manning has served on the Clinical Affairs and Quality Committee for ASTRO. Previously, he was a member of the ASTRO Congressional Relations Subcommittee. During residency, he was elected Chairman of the Executive Committee for the Association of Residents in Radiation Oncology (ARRO). He was named a Fellow in ASTRO in 2019.

Manning is committed to successful community cancer research. In the past three years, he has co-authored over twenty articles published in the Journal of Clinical Oncology, Journal of Applied Clinical Medical Physics, the “Red Journal” and mainstream media.

In 2016, Manning’s project to drastically reduce costs in oncology received the ACCC Innovator Award. The project focused on “Hotspotters.” He showed that costs are less driven by expensive cancer treatment and result from gaps in coordination of services in medically complex patients. Manning is active with his hospital’s Next Generation ACO, having served as the Oncology Division Chief and Operating Committee member.

Manning is a member of the Greensboro Health Disparities Collaborative. GHDC conducted ACCURE. This study was successful in eliminating racial disparity in cancer care.

Manning is board-eligible in Clinical Informatics. He has served on the EPIC Oncology and Radiation Oncology Steering Committees.

Manning is a past President of the Greater Greensboro Society of Medicine and has served on the ASCO Membership Committee.

Manning and his wife Allison have three daughters. He loves dragging their suitcases through airports, playing music and walking his dogs.

Dr. Noel is an Assistant Professor and Meadows Foundation Fellow in Quality of Life in the Rural Environment at the Steve Hick’s School of Social Work. Her research investigates the influence of inequities in social drivers of health and access to mental health services on the utilization of timely medical treatment, particularly within residentially isolated rural communities. She has a passion for conducting community-based system science research and has a wealth of experience engaging communities, social scientists, mental health professionals, and medical practitioners in such research partnerships.

Dr. Noel’s work in rural health equity has also been recognized nationally. She is on the Board of Directors for the Association of Community Cancer Centers and the Board of Directors of the Association of Oncology Social Workers.

Dr. Noel earned a Ph.D. in social work from Washington University in St. Louis. She also earned a master’s degree in social service administration from the University of Chicago, and a bachelor’s degree in pre-medicine from the University of Michigan.

I have been the Gundersen Health System Cancer Center Director for 10 years. In that period, I have seen many changes driving cancer care within our organization such as precision medicine, staffing shortages, changing treatment paradigms and re-imbursement models just to name a few. In this process of change, cancer care has become a much more complex disease with multiple providers routinely involved in the care of patients and with that it is a significantly more expensive disease to treat. Along with the constant change in cancer care, I too have evolved both as a physician as well as a community cancer center leader.

As cancer center director I have been involved in multiple aspects of the business of cancer care, human resources, financing, risk management, marketing, and information technology. This new set of challenges extended far beyond my medical school training and brought me to pursue an MBA which I completed in May of 2019. I have also realized that as much as I could control and transform within our organization, factors external to our organization are having an outsized influence on cancer care, namely reimbursement models and health care policy decisions. These two factors have led me to be engaged in our state society, the Wisconsin Association of Hematology and Oncology (WAHO) as well our state CDC sponsored program the Wisconsin Cancer Collaborative (WCC) where I sit on the steering committee and chair the policy committee. I have also been involved with the American Society of Clinical Oncology (ASCO). At ASCO I volunteered time with several committees including the Government Relations Committee (GRC) for 3 years as well as leading the State Affiliate Council (SAC) for an additional 3 years. It is with this backdrop that I would like to serve on the Board of Trustees for the Association of Community Cancer Centers (ACCC). I believe that the experience I bring and more importantly the added perspective I could gain, would help me best advocate for the mission of ACCC as well as the patients I treat, and the cancer center I lead. I humbly look forward to the opportunity to serve on the Board of Trustees for the ACCC.

Lori Schneider is an oncology operations manager at Green Bay Oncology and has worked in healthcare for over 25 years. As an operations manager, Schneider oversees the organization’s financial counseling, social work, medical records, reception, and dietitian teams, as well as provider scheduling and credentialing. She joined Green Bay Oncology as a receptionist and later transferred to revenue cycle, where she worked in accounts receivable. In 2006, Schneider developed the financial counseling role at Green Bay Oncology before transitioning to business office manager and, more recently, operations manager roles. 

She is a past chairperson for the Association of Community Cancer Centers (ACCC) Financial Advocacy Network and is currently an ACCC Board Member. Schneider has presented at several conferences on the importance of financial counseling in oncology, including what is needed to have a centralized team that cares for patients' financial and insurance needs (e.g., prior authorizations and financial assistance for medical, radiation, surgical, gynecological, and pediatric oncology). Additional conference topics include the importance of utilizing pharmaceutical and specialty pharmacy representatives to help your cancer program and how to enhance your financial counseling program. Schneider and her team have also assisted cancer programs and practices nationally and locally, including helping them establish and enhance their own financial counseling programs.

Leigha Senter, MS, LGC, FACCC, is a licensed genetic counselor and clinical professor at The Ohio State University’s James Cancer Hospital and Solove Research Institute where she specializes in cancer genetics risk assessment in women with gynecologic cancers. She is the Associate Director of the Division of Human Genetics.

Senter has more than 20 years of research experience in hereditary cancers with a primary focus in BRCA gene-related projects with more than 100 peer reviewed publications. She is currently a board member for the Association of Community Cancer Centers.

Senter earned a bachelor's degree in molecular genetics from The Ohio State University in Columbus, Ohio, and a master's degree in genetic counseling from the University of Pittsburgh in Pittsburgh, Pennsylvania

Dr. Afreen Shariff is an Associate Professor of Medicine at Duke University and a nationally recognized Endocrinologist and with a focus on endocrine disease in cancer patients. Dr. Shariff is a transformational leader who has created and led several successful initiatives over the years. She is the Founding Director for the Duke Endo Oncology Program, serves as the Associate Director for the Duke Cancer Therapy Toxicity Program, hosts and produces a medical podcast series, Checkpoint NOW and serves as the founding Chair of the Onco-Endocrinology Special interest Group through The Endocrine Society. She is also the Co-founder of Citrus Oncology, a virtual consultative platform for side effect management in cancer patients. Her research interests include optimizing healthcare through value-based, patient-centric clinical and educational programs targeted at improving access and reducing health costs while managing complex oncology patients effectively. She is a Principal Investigator for several studies including a study focused at creating a novel machine learning model to predict hospitalizations from immunotherapy-related adverse events up to 2 weeks before the expected event which was featured in the Science magazine. She is the recipient of the 2023 ACCC Innovator Award, has published in numerous peer-reviewed journals and speaks at several regional and national conferences. Timely access, patient-provider-subspecialist education, care navigation and predicting and preventing hospital admissions from toxicities using AI has been the focus of her career.

Cardinale B. Smith, MD, PhD is a Professor of Medicine in the Division of Hematology and Medical Oncology and the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai, Associate Director for Community, Outreach and Engagement in the Tisch Cancer Institute and the Chief Quality Officer for Cancer Services, Tisch Cancer Center. She is a medical oncologist and palliative care physician whose clinical practice is focused on lung cancer and palliative care. Her research interests focus on doctor-patient communication, evaluating treatment disparities in cancer care, determinants of cancer patients’ quality of care, characterizing barriers to optimal cancer and palliative care and developing approaches to eliminating those barriers among racial and ethnic minorities. Dr. Smith is a 2013 recipient of a mentored research scholar grant from the American Cancer Society to evaluate determinants of disparities in the utilization of palliative care among patients with lung cancer. She was a co-investigator on a Patient Centered Outcomes Research Institute grant to teach and enable goals of care conversations among oncologists. Additionally, she is the recipient Sojourn’s Scholar Leadership Grant and an R01 from the National Cancer Institute to evaluate the role of implicit bias among oncologists on minority cancer patient outcomes. Dr. Smith has had numerous publications in peer-reviewed journals, and in 2015 was named one of the Top 40 Inspirational Leaders under 40 by the American Academy of Hospice and Palliative Medicine.